Mini Review
Published on 14 Apr 2020
Systemic Mastocytosis: Following the Tyrosine Kinase Inhibition Roadmap
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2020.00443
- 17,998 views
- 29 citations
6 articles related to "Kit D816v"
Articles
Case Report
Published on 18 Oct 2024
Case Report: Multidisciplinary management of a patient with indolent systemic mastocytosis and refractory symptoms
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1401187
- 4,599 views
- 1 citation
Review
Published on 27 May 2025
Utility of tryptase genotyping in the screening, diagnosis, and management of systemic mastocytosis
in Genetics and Epidemiology
Frontiers in Allergy
doi 10.3389/falgy.2025.1599358
- 3,878 views
- 2 citations
Case Report
Published on 10 Aug 2023
Case Report: Molecular and microenvironment change upon midostaurin treatment in mast cell leukemia at single-cell level
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1210909
- 5,102 views
- 3 citations
Case Report
Published on 30 Nov 2021
Case Report: Evolution of KIT D816V-Positive Systemic Mastocytosis to Myeloid Neoplasm With PDGFRA Rearrangement Responsive to Imatinib
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.734025
- 3,232 views
Original Research
Published on 26 Jul 2022
The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2022.930945
- 6,225 views
- 16 citations